Table. 2. Progression profile of tumor growth kinetics.
| Series | Measurement of Tumor volume (mm3) in days | ||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | 4 | 7 | 10 | 13 | 16 | 19 | 22 | 25 | 28 | 31 | 34 | 37 | 40 | 42 | |
| VC | 70.43 ± 27.69 | 92.22 ± 30.53 | 129.50 ± 41.21 | 180.1 ± 66.4 | 281.16 ± 82 | 368.94 ± 104.75 | 494.2 ± 169.17 | 684.19 ± 285.16 | 787.98 ± 368.92 | 957.89 ± 475.2 | 1158.47 ± 572.74 | 1288.05 ± 688.12 | 1356.71 ± 789.82 | 1467.77 ± 927.32 | 1546.81 ± 1027.95 |
| Low | 74.20 ± 20.31 | 110.48 ± 33.49 | 159.95 ± 55.49 | 219.7 ± 92.89 | 295.34 ± 119.38 | 360.74 ± 161.16 | 430.23 ± 247.02 | 527.36 ± 303.52 | 641.63 ± 371.7 | 677 ± 323.78 | 709.6 ± 278.73 | 725.53 ± 265.85 | 858.46 ± 415.51 | 924.12 ± 449.9 | 981.84 ± 482.02 |
| Mid | 70.11 ± 18.74 | 87.62 ± 21.07 | 114.93 ± 24.76 | 148.22 ± 38.96 | 178.03 ± 45.06* | 214.99 ± 61.03* | 241.07 ± 53.57* | 283.92 ± 49.56* | 347.12 ± 50.73* | 384.89 ± 68.09* | 429.21 ± 82.23* | 440.51 ± 120.43* | 507.67 ± 220.26* | 521.22 ± 231.02 | 529.1 ± 216.29 |
| High | 71.85 ± 5.99 | 92.27 ± 7.69 | 119.84 ± 14.57 | 154.79 ± 27.42 | 193.84 ± 31.46* | 246.7 ± 54.93* | 294.72 ± 74.85* | 343.84 ± 88.27* | 406.58 ± 92.88* | 451.27 ± 110.63* | 515.49 ± 147.87* | 548.56 ± 174.96* | 594.89 ± 191.39 | 615.45 ± 202.63 | 628.28 ± 211.79 |
VC, vehicle control; Low dose, 500 mg/kg bw; Mid dose, 1,000 mg/kg bw; High dose, 2,000mg/kg bw; BW, body weight. *P < 0.05 vs. vehicle control group.